Mahalunkar, S. and Yadav, A.S. and Gorain, M. and Pawar, V. and Braathen, R. and Weiss, S. and Bogen, B. and Gosavi, S.W. and Kundu, G.C. (2019) Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer. International Journal of Nanomedicine., 14. pp. 8285-8302.

Tomar, D. and Yadav, A.S. and Kumar, D. and Bhadauriya, G. and Kundu, G.C. (2019) Non-coding RNAs as potential therapeutic targets in breast cancer. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms.

Prasad, R. and Chauhan, D.S. and Yadav, A.S. and Devrukhkar, J. and Singh, B. and Gorain, M. and Temgire, M. and Bellare, J. and Kundu, G.C. and Srivastava, R.A. (2018) biodegradable fluorescent nanohybrid for photo-driven tumor diagnosis and tumor growth inhibition. Nanoscale, 10 (40). pp. 19082-19091. ISSN 10(40):19082-19091

Yadav , A.S. and Pandey, P.R. and Butti , B. and Radharani , NNV. and Roy, R. and Bhalara, S.R. and Gorain , M. and Kundu , G.C. and Kumar , D. (2018) The biology and therapeutic implications of tumor dormancy and reactivation. Front Oncol. , 8. p. 72.

Kumar, D. and Haldar, S. and Gorain , M. and Kumar , S. and Mulani, F.A. and Yadav, A.S. and Miele, L. and Thulasiram, H.V. and Kundu , G.C. (2018) Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer. 2018 Jan 8;18(1):52, 18 (1). p. 52.

Butti , R and Das, S and Gunasekaran , V.P. and Yadav, A.S. and Kumar, D. and Kundu , G.C. (2018) Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Molecular Cancer, 17 (34).